pGy2 program
Residency Program Director
-
Tracy Wiczer, PharmD, BCOP
- PGY2 Oncology Residency Program Director, The James Cancer Hospital at The Ohio State University
- PGY2 Oncology, The James Cancer Hospital at The Ohio State University
- PGY1, The Jewish Hospital-Mercy Health, Cincinnati, Ohio
- PharmD, University of Cinicinnati
Previous Year Residents
-
Pooja Kumar
Clinical Pharmacy Specialist in Hematology/Oncology-The James Cancer Hospital Solove Research Institute -
Alycia Hatashima
Clinical Pharmacy Specialist, Oncology, Seattle Cancer Care Alliance -
Dat Le
Clinical Pharmacy Specialist, Outpatient Gastrointestinal/Neuroendocrine Cancers Clinic at Martha Morehouse -
Delaney Wolfe
Clinical Pharmacy Specialist, Bone Marrow Transplant, Franciscan Health, Indianapolis, IN -
Tracelyn Freeman
Inpatient/Outpatient BMT and Acute Leukemia, The James Cancer Hospital Solove Research Institute -
Leylah Azali
Outpatient Clinical Hematology Specialist, Houston Methodist Hospital -
Danielle Murphy
Heme/Onc Cell Therapy Clinical Pharmacy Specialist, Rush University Medical Center, Chicago -
Kristen Nymberg
Inpatient/Outpatient GU Medical Oncology Pharmacy Specialist, The James Cancer Hospital Solove Research Institute -
LeeAnn Geraghty
Clinical Hematology/Oncology Specialist Pharmacist, Norton Healthcare, Louisville, KY -
Allison Grana
Inpatient/Outpatient GU Medical Oncology Clinical Pharmacy Specialist, MD Anderson Cancer Center, Houston, TX -
Brendan Rasor
Pharmacist (Outpatient Infusion) Kettering Health Network and the Kettering Cancer Care Pavilion, Dayton OH -
Justin Tossey
Inpatient/Outpatient BMT and Acute Leukemia, The James Cancer Hospital Solove Research Institute
About the PGY2 Hematology/ Oncology Residency Program
Residency Sites
The Ohio State University Comprehensive Cancer Center – James Cancer Hospital is ranked nationally as one of the top hospitals for cancer care, maintaining an “exceptional” rating – the highest descriptor given by the National Cancer Institute, and is the third largest cancer center in the nation. Opened in December 2014, with 21 floors spanning 1.1 million square feet, the new James Cancer Hospital and Solove Research Institute revolutionizes the way cancer prevention and care are provided, with over 200 specialized oncologists and cancer researchers working side-by-side to unlock the mysteries of what causes cancer and, using those discoveries, transition from cancer treatment to cancer prevention.
Read More
This 356-bed adult cancer clinical care facility, including a 36-bed blood and marrow transplant unit, is a member of the National Comprehensive Cancer Network, the National Cancer Institute’s National Clinical Trial Network— notably one of only four centers funded by the NCI to conduct both Phase I and II clinical trials on novel anticancer drugs, achieved Magnet® designation for excellence in patient care, and is fully accredited by the Joint Commission, the American College of Surgeons Common on Cancer and the Foundation for the Accreditation of Cellular Therapy. The center includes six outpatient chemotherapy infusion clinics, dispensing an estimate of over 75,000 doses of chemotherapy annually. The Department of Pharmacy consists of inpatient and outpatient hematology/oncology clinical specialist pharmacists, pain and palliative medicine pharmacists, anti-coagulation pharmacists, cancer informatics pharmacists, medication assistance pharmacists, and Hematology/Oncology specialty practice pharmacy residents.
The James Cancer Hospital at The Ohio State University offers a one-year postgraduate year two (PGY2) ASHP accredited oncology pharmacy residency program. The clinical pharmacy program is designed to align with our subspecialized disease specific model allowing residents the opportunity to train with clinical specialists who are experts in their subspecialty in both inpatient and ambulatory clinic setting. The program allows residents to develop their hematology/oncology knowledge base including cancer treatment, supportive care, and the role of clinical trials in this patient population. Upon completion of the program, the resident will have the skillset necessary to work as a respected member of a multi-disciplinary hematology/oncology patient care team.
KEY ROTATIONS/EXPERIENCES
The resident will complete a combination of rotations and longitudinal experiences designed around the core objectives specified by ASHP in addition to the resident’s interest.
- Inpatient Acute Leukemia
- Bone Marrow Transplantation
- Inpatient Benign Hematology and Lymphoma/Myeloma
- Inpatient Oncology
- Outpatient Hematology Clinics
- Benign Hematology
- Lymphoma
- Myeloma
- BMT and Acute Leukemia
- Outpatient Oncology Clinics
- Breast Cancer
- Gastrointestinal Cancer
- Gynecologic Cancer
- Lung Cancer
- Genitourinary Cancer
- Head & Neck/Sarcoma
- Melanoma
- Neuro-oncology
- Other Outpatient Clinics
- Oncology Anticoagulation
- Clinical Trials Unit
- Pain and Palliative Care
- Investigational Drug Service
- Oncology Administration
- Informatics
- Teaching
- Infectious Disease
- Medication Safety
Key Preceptors
Learn more about the Hematology/Oncology key preceptors:
Read MoreINPATIENT/OUTPATIENT HEMATOLOGY
Jessica Dempsey, PharmD, BCOP
Outpatient Multiple Myeloma
Emily Dotson, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma
Bryant Clemons, PharmD
Inpatient/Outpatient BMT and Acute Leukemia
Rebecca Evers, PharmD, BCOP
Outpatient Hematology
Tracelyn Freeman, PharmD
Inpatient/Outpatient BMT and Acute Leukemia
Natalia Gut, PharmD, BCOP
Hematology Float
Lindsay Hazelden, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma
Dan Kendzierski, PharmD, BCOP
Outpatient Hematology/Oncology
Jordan Lundberg, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma
Marcin Puto, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia
Justin Tossey, PharmD
Inpatient/Outpatient BMT and Acute Leukemia
Ally Waller, PharmD, BCOP
Inpatient/Outpatient BMT and Acute Leukemia
Tracy Wiczer, PharmD, BCOP
Inpatient/Outpatient Benign Hematology, Chronic Lymphocytic Leukemia, and Lymphoma
INPATIENT/OUTPATIENT ONCOLOGY
Matt Arango, PharmD, BCOP
Outpatient Gastrointestinal Cancer
Brianna Archambeau, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Melanoma
Heather Armbruster, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Melanoma
Michael Berger, PharmD, BCOP
Outpatient Breast Cancer
Stephanie Collins, PharmD, BCOP
Outpatient Breast Cancer
Tyler Dickerson, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Gynecologic Cancers
Eric Fela, PharmD
Inpatient Medical Oncology/Outpatient Gynecologic Cancers
Megan Hinkley, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Genitourinary Cancers
Sarah Hoffman, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Head & Neck Cancer/Sarcoma
Gretchen Junker, PharmD
Oncology Float
Kristen Nymberg, PharmD
Inpatient Medical Oncology/Outpatient Genitourinary Cancers
Josh Reardon, PharmD, BCOP
Outpatient Gastrointestinal Cancer
Tom Schultz, PharmD, BCOP
Inpatient Medical Oncology/Outpatient Head & Neck Cancer/Sarcoma
Michael Smith, PharmD, BCOP
Outpatient Lung Cancer
Greg Samijlenko, PharmD,BCPS, BCOP
Outpatient Neuro-oncology
Craig Vargo, PharmD, BCOP
Outpatient Breast Cancer
Sherry Vogt, PharmD, BCOP
Outpatient Genitourinary Cancers
HEMATOLOGY/ONCOLOGY ANTICOAGULATION
Paige Erdeljac, PharmD, BCACP
Hematology/Oncology Anticoagulation
Stephanie Yager, PharmD
Hematology/Oncology Anticoagulation
PAIN AND PALLIATIVE MEDICINE
Jessica Hirsch, PharmD
Palliative Medicine
Gary Houchard, PharmD
Palliative Medicine
Justin Kullgren, PharmD, CPE
Palliative Medicine
Kyle Quirk, PharmD
Palliative Medicine
Maureen Saphire, PharmD, CGP, CDP
Palliative Medicine
OTHER HEMATOLOGY AND ONCOLOGY PRECEPTORS
Amber Hartman, PharmD
Medication Safety
Naomi Digiantonio, PharmD, BCPS
Clinical Trials Unit
ADMINISTRATION
Hallie Barr, PharmD, BCOP
Pharmacy Manager
Investigational Drugs Services
Janinah Barretto, PharmD, MS
Pharmacy Manager
Oncology Informatics
Mitch Dorn, PharmD, MS
Assistant Director
Morgan Forshay, PharmD, MS, BCPS
Pharmacy Manager, Inpatient Oncology
Sarah Hudson-Disalle, PharmD
Pharmacy Manager
Medication Assistance
Julie Kennerly, PharmD, MS, MHA, BCPS
Assistant Director of Pharmacy
Clinical and Specialty Pharmacy Services
Ben Lopez, PharmD, MS, MHA, BCPS
Director, Enterprise Operations
Stephen Polley, PharmD, MPA, MS, BCPS
Assistant Director
Selected RESIDENT RESEARCH
- Evaluation of the incidence and risk factors associated with major cardiovascular events in patients receiving acalabrutinib therapy. Azali L
- Hypomethylating agents with or without venetoclax in adult patients with acute myeloid leukemia. Freeman T
- Comparison of Fludarabine and Cytarabine with Granulocyte Colony Stimulating Factor vs. Mitoxantrone, Etoposide and Cytarabine as Salvage Chemotherapy in Relapsed/Refractory Acute Myeloid Leukemia. Murphy D
- Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies. Nymberg K
Benefits and Additional Requirements
Application Deadline: January 2
Start Date: July 1
Annual Salary – $48,500
Vacation Days – 10 Days
Staffing Requirement – 20 weekends per year
Completion of a Major Research Project

You must be logged in to post a comment.